Understanding Insulin-like Growth Factor-1 Insulin-like growth factor-1 (IGF-1), formerly known as somatomedin or somatomedin C, has a single chain 70-amino acid polypeptide cross-linked by 3 disulfide bridges. Although IGF-1 provides several benefits similar to insulin such as lower blood sugar levels, the key difference is that insulin mediates mainly a metabolic response, whereas IGF-1 mediates growth-promoting effects (Source)
When the mitochondrial electron transport chain is protected from oxidative interference, the enzymes responsible for ATP synthesis can function more efficiently
In adults with growth hormone receptor deficiency, eight weeks of rhIGF-1 therapy significantly increased whole-body protein synthesis, decreased protein oxidation and increased lean body mass while reducing fat mass, demonstrating enhanced muscle anabolism and nutrient utilization in humans
Compound Specifications CAS 170851-70-4 MW 711.85 Da Purity 99.524% Documentation & Lab Use Form: Lyophilized research material Documentation: Review the product label, batch records, and applicable laboratory SOPs before accessioning